177Lu-DTPA-omburtamab
N/A
Report date: 2025/09/12 15:57:55
Base Information
Drug Name177Lu-DTPA-omburtamab
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesY-Mabs Therapeutics Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A